6th RSC / SCI symposium on GPCRs in Medicinal 91AV

13 June 2016 08:30 - 15 June 2016 12:00, Verona, Italy

Introduction

The key role of G-protein coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will support the sixth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches. The conference programme will cover: First disclosures of clinical candidates Case studies in GPCR drug discovery and development New structural biology and drug design Allosteric modulation & biased signalling evening networking reception - poster session - conference dinner - trade exhibition opportunities - accommodation identified for direct booking

Deadlines

Useful links

Downloads

Speakers

Madan Babu Medical Research Council LMB, United Kingdom
Roland Bürli AstraZeneca/MedImmune, United Kingdom
Bernadette Byrne Imperial College London, United Kingdom
Olivier Corminboeuf Actelion, Switzerland
Bruce Ellsworth Bristol-Myers Squibb, United States
Andreas Haupt Abbvie, Germany
Vsevolod (Seva) Katritch University of South California, United States
Fiona Marshall Heptares Therapeutics, United Kingdom
Jon Mason Heptares Therapeutics, United Kingdom
Stefano Moro University of Padova, Italy
Ravi Nargund Merck, United States
Roger Norcross Roche, Switzerland
Graeme Semple Arena Pharmaceuticals Inc, United Kingdom
Hayley Sharpe Genentech, United States
Gyorgy Snell Takeda California, United States
Christofer Tautermann Boehringer Ingelheim, Germany
Irina Tikhonova Queen's University Belfast, United Kingdom
Travis Wager Pfizer US, United States
Zara Sands UCB, Belgium

Sponsorship & supporting organisations

Venue

Aptuit

Aptuit, Via Alessandro Fleming 4, Verona, 37135, Italy

Useful links

Committee

Organised by

Contact information

91AV

Share: